BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  Vasogen Gives Update On Phase III Celacade Trials

  December 7, 2005

   · 

  8 min read
• Business

  INEX Pharmaceuticals Appoints President & CEO And Updates Reorganization Timetable

  December 7, 2005

   · 

  5 min read
• Drug Development

  FDA Provides Guidance On Advanced Life Sciences’ Pivotal Phase 3 Clinical Protocol Evaluating Cethromycin In Community Acquired Pneumonia

  December 7, 2005

   · 

  4 min read
• Deals

  Phase III Medical Inc. Signs Definitive Agreement To Acquire NeoStem, Inc., An Adult Stem Cell Company

  December 7, 2005

   · 

  1 min read
• Drug Development

  Favrille, Inc. Announces Long-Term Follow-Up Data From Phase 2 Clinical Trial Of FavId To Be Presented At American Society of Hematology Annual Meeting In Atlanta

  December 7, 2005

   · 

  2 min read
• Drug Development

  Stem Cell Therapeutics And Medicon A/S Complete Dosing Of Patients In Phase I Study Of NTx(TM)-265

  December 7, 2005

   · 

  3 min read
• Drug Development

  TolerRx, Inc. Initiates Three Clinical Trials In Autoimmune Indications

  December 7, 2005

   · 

  4 min read
• Business

  BioVeris Completes New License Agreement With The University of Massachusetts - Amherst

  December 7, 2005

   · 

  5 min read
• Pharm Country

  Bristol-Myers Squibb Company Announces Dividend

  December 7, 2005

   · 

  1 min read
• Biotech Bay

  Genelabs Technologies, Inc. Announces Board Approval Of Reverse Stock Split

  December 7, 2005

   · 

  4 min read